Variable | P013 (N = 107) | Reference pertuzumab (N = 107) |
---|---|---|
The most common AEs | ||
 Anaemia | 103 (96.26) | 100 (93.46) |
 Thrombocytopenia | 69 (64.49) | 70 (65.42) |
 Nausea | 64 (59.81) | 71 (66.36) |
 Diarrhoea | 61 (57.01) | 67 (62.62) |
 Leukopenia | 56 (52.34) | 51 (47.66) |
 Neutropenia | 49 (45.79) | 47 (43.93) |
 Vomiting | 46 (42.99) | 56 (52.34) |
 Abdominal pain | 43 (40.19) | 37 (34.58) |
 Pain | 38 (35.51) | 34 (31.78) |
 Dyspepsia | 37 (34.58) | 31 (28.97) |
The most common Grade 3, 4 AEs | ||
 Anaemia | 15 (14.02) | 10 (9.35) |
 Thrombocytopenia | 13 (12.15) | 14 (13.08) |
 Neutropenia | 11 (10.28) | 10 (9.35) |
 Diarrhoea | 10 (9.35) | 12 (11.21) |
 Alanine aminotransferase increased | 3 (2.80) | 5 (4.67) |
 Abdominal pain | 2 (1.87) | 1 (0.93) |
 Diarrhoea infectious | 2 (1.87) | 1 (0.93) |
 Pyrexia | 2 (1.87) | 1 (0.93) |
 Vomiting | 0 (0.00) | 3 (2.80) |
Serious AEs | ||
 | 24 (22.43) | 15 (14.02) |